Complete androgen insensitivity syndrome: diagnosis and multidisciplinary management
Main Article Content
Keywords
Androgen Resistance Syndrome, Patient Care Management, Mexico, Amenorrhea, Androgens
Abstract
Background: Complete androgen insensitivity syndrome (CAIS) is a sexual differentiation disorder, caused by a defect in the androgen receptor gene (AR; OMIM# 313700). It is characterized by the resistance of target tissues to the action of testosterone, which prevents normal male genital development. The objective is to describe a family case of CAIS and highlight the importance of multidisciplinary medical management and early diagnosis of this syndrome.
Clinical case: We present two cases of SICA in a Mexican family. Case 1: 18-year-old female patient with primary amenorrhea and a history of surgery at an early age, without performing gonadectomy. Case 2: 11-year-old female patient who, due to the history of her sister, underwent surgery at that age. In both patients, absence of uterus and ovaries, hypoplastic vagina and male gonads is reported. The 46,XY karyotype was detected with the GTG and CBG band technique and fluorescent in situ hybridization with the presence of the Y chromosome in 100% of the cells analyzed. Although both patients were identified with their assigned sex, they were referred to the institution’s psychiatric clinic.
Conclusions: The importance of multidisciplinary management for the diagnosis of SICA at an early age is discussed, in order to make decisions regarding the treatment and management of patients, avoiding malignant transformation of the male gonads.
References
Galani A, Kitsiou-Tzeli S, Sofokleous C, Kanavakis E, Kalpini-Mavrou A. Androgen insensitivity syndrome: clinical features and molecular defects. Hormones (Athens). 2008;7(3):217-29. doi: 10.14310/horm.2002.1201.
Batista RL, Frade Costa EM, Rodrigues A de S, Gomes NL, Faria JA Jr, Nishi MY, et al. Androgen insensitivity syndrome: a review. Arch Endocrinol Metab. 2018;62(2):227-35. doi: 10.20945/2359-3997000000031.
Federación Mexicana de Enfermedades Raras. Síndrome de insensibilidad completa a los andrógenos. México: Femexer.org; 30 de abril de 2014. Disponible en: http://www.femexer.org/3522/ sindrome-de-insensibilidad-completa-a-los-androgenos/
Solana MA, Paris A. Síndrome de insensibilidad completa a los andrógenos. SAEGRE. 2013; 20(1):36-9. Disponible en: http://www.saegre.org.ar/revista/numeros/2013/n1/36-40- 2013n1.pdf.
Farias-Cortés JD, Minakata-Ochoa F, Sedano-Portillo I. Síndrome de insensibilidad completa a los andrógenos: reporte de un caso, ilustración del manejo quirúrgico. Revista Mexicana de Urología. 2014;74(2):117-22. doi: 10.1016/ S2007-4085(15)30023-9.
Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA. Androgen insensitivity syndrome. Best Pract Res Clin Endocrinol Metab. 2015;29(4):569–80. doi: 10.1016/j.beem.2015.04.005.
Li BK, Ding Q, Wan XD, Wang X. Clinical and genetic characterization of complete androgen insensitivity syndrome in a Chinese family. Genet Mol Res 2011;10(2):1022-31. doi: 10.4238/vol10-2gmr1130.
Wisniewski AB, Migeon CJ, Meyer-Bahlburg HFL, Gearhart JP, Berkovitz GD, Brown TR, et al. Complete androgen insensitivity syndrome: long-term medical, surgical, and psycho-sexual outcome. J Clin Endocrinol Metab. 2000;85(8):2664- 9. doi: 10.1210/jcem.85.8.6742.
Li L, Liu WM, Liu MX, Zheng SQ, Zhang JX, Che FY, et al. A missense mutation in the androgen receptor gene causing androgen insensitivity syndrome in a Chinese family. Asian J Androl. 2017;19(2):260-1. doi: 10.4103/1008-682X.172647.
Tadokoro-Cuccaro R, Hughes IA. Androgen insensitivity syndrome. Curr Opin Endocrinol Diabetes Obes. 2014;21(6):499- 503: doi: 10.1097/MED.0000000000000107.
Oakes MB, Eyvazzadeh AD, Quint E, Smith YR. Complete androgen insensitivity syndrome: a review. J Pediatr Adolesc Gynecol 2008;21(6):305-10. doi: 10.1016/j.jpag.2007.09.006.
Holterhus PM, Wiebel J, Sinnecker GHG, Brüggenwirth HT, Sippell WG, Brinkmann AO, et al. Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome. Pediatr Res. 1999;46(6):684-90. doi: 10.1203/ 00006450 -199912000-00009.
Hughes IA, Houk C, Ahmed S F, Lee P A; LWPES1/ESPE2 Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-63. doi: 10.1136/adc.2006.098319.
Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou, K, MacDougall J. Androgen insensitivity syndrome. Lancet. 2012; 380(9851): 1419-28. doi: 10.1016/S0140 -6736(12)60071-3.
Indig G, Serrano M, Dalke KB, Nwadiogo IE, Grimstad F. Clinician Advocacy and Intersex Health: A History of Intersex Health Care and the Role of the Clinician Advocate Past, Present, and Future. Pediatric Annals. 2021;50(9):e359-65. doi: 10.3928/19382359-20210816-01.
Bransford, CL.Reconciling Paternalism and Empowerment in Clinical Practice: An Intersubjective Perspective. Social Work. 2011;56(1):33-41. doi: 10.1093/sw/56.1.33.
Wiesemann C, Ude-Koeller S, Sinnecker GHG, Thyen U. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. European Journal of Pediatrics. 2010;169(6):671-9. doi: 10.1007/s00431-009-1086-x.
Reis E, McCarthy MW. What Hospitalists Should Know About Intersex Adults. Perspect Biol Med. 2016;59(3):391-8. doi: 10.1353/pbm.2016.0033.
Khollová S, Hrdonková E, Pomahačová R. Androgen insensitivity syndrome - case report. Ceska Gynekol. 2014;79(1): 38-42.
Kar B, Sivamani S, Kundavi S, Varma TR. Complete androgen insensitivity syndrome in three generations of Indian pedigree. J Obstet Gynaecol India. 2016;66(Suppl 1):358-62. doi: 10.1007/s13224-015-0736-3.
Nichols JL, Bieber EJ, Gell JS. Case of sisters with complete androgen insensitivity syndrome and discordant Müllerian remnants. Fertil Steril. 2009;91(3):932.e15-8. doi: 10.1016/j. fertnstert.2008.09.027.
Verim L. Complete Androgen Insensitivity Syndrome in Three Sisters. Int J Fertil Steril. 2014;7(4):353-6.